canada tirzepatide for Weight Loss & Metabolic Support Tirzepatide | Research-Grade GLP Peptide

Foundayo (Orforglipron) Foundayo, approved in April 2026, is a flexible oral option for weight loss

Oral tirzepatide delivers this dual-hormone approach in tablet form for patients who prefer a non-injectable option

Mutations in the genes that code for leptin or for the receptor can cause morbid obesity early in life, as was shown in rodents

doi: 10.2165/11633940-000000000-0000010.1007/BF03261931 29 MarxWTeleniLOpieRSKellyJMarshallSItsiopoulosCet al

Patients with significant diagnosed GI conditions (confirmed IBD, documented gastric ulcers, established gastroparesis) are encouraged to share their GI specialist reports at the consultation so the physician can integrate BPC-157 appropriately alongside any existing conventional treatment

This is Hims & Hers